Metformin treatment reduced plasma C-reactive protein levels and monocyte release of tumor necrosis factor - and interleukin-@ , as well as tended to reduce monocyte release of interleukin-@ and monocyte chemoattractant protein-@ , which was accompanied by an improvement in insulin sensitivity .